Pages that link to "Q43990941"
Jump to navigation
Jump to search
The following pages link to Depot leuprolide acetate for treatment of precocious puberty (Q43990941):
Displaying 14 items.
- Multicenter clinical trial of leuprolide acetate depot (Luphere depot 3.75 mg) for efficacy and safety in girls with central precocious puberty (Q33635297) (← links)
- Central precocious puberty: current treatment options (Q33980998) (← links)
- Developments in the control of testicular function (Q34249428) (← links)
- Management and outcome of central precocious puberty (Q34549875) (← links)
- Efficacy of Leuprolide Acetate 1-Month Depot for Central Precocious Puberty (CPP): Growth Outcomes During a Prospective, Longitudinal Study (Q35173681) (← links)
- Gelatin device for the delivery of growth factors involved in endochondral ossification. (Q36336015) (← links)
- Drug Treatment in Precocious Puberty (Q36663803) (← links)
- Southwestern Internal Medicine Conference: New Developments in the Diagnosis and Treatment of Sexual Precocity (Q36731505) (← links)
- The Treatment of Precocious Puberty (Q37085207) (← links)
- Pros and cons of GnRHa treatment for early puberty in girls (Q38202811) (← links)
- Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders (Q40398462) (← links)
- Diagnosis and management of precocious puberty (Q46790161) (← links)
- Two-year results of treatment with depot leuprolide acetate for central precocious puberty (Q46910376) (← links)
- Effects of pomegranate extract in supplementing gonadotropin-releasing hormone therapy on idiopathic central precocious puberty in Chinese girls: a randomized, placebo-controlled, double-blind clinical trial. (Q48350443) (← links)